Global Idiopathic Pulmonary Fibrosis Treatment Market Forecast: Trends, Share, and Growth Drivers
The global Idiopathic Pulmonary Fibrosis (IDF) treatment market size was USD 3.51 Billion in 2022 and is expected to register a rapid revenue CAGR of 6.2% during the forecast period. Increasing Research & Development (R&D) activities and rapid technological advancements in pulmonary fibrosis are key factors driving market revenue growth. The latest research on the Idiopathic...
0 Comments 0 Shares 325 Views 0 Reviews